China
Africa
Explore chapters and articles related to this topic
Digital Health Technologies and Innovations
Published in Kelly H. Zou, Lobna A. Salem, Amrit Ray, Real-World Evidence in a Patient-Centric Digital Era, 2023
Kelly H. Zou, Mina B. Riad, Shaantanu Donde, Joan van der Horn, Tarek A. Hassan
Remote patient monitoring, (e.g., telehealth, mHealth) help in keeping patients outside hospitals and protect the fragile and immunocompromised from acquiring nosocomial infections especially during the fulminant times in the pandemic (Clinical Management of COVID-19).
IoT in the Healthcare Sector
Published in Govind Singh Patel, Seema Nayak, Sunil Kumar Chaudhary, Machine Learning, Deep Learning, Big Data, and Internet of Things for Healthcare, 2023
A.K. Awasthi, Sanjeev Kumar, Arun Kumar Garov
The most common application of IoT devices in the healthcare industry is remote patient monitoring. The devices based on IoT can collect health metrics like heart rate, blood pressure, temperature, and many more automatically from patients who are not physically present in a healthcare facility. This eliminates the need for patients to travel to the health service providers.
Telehealth Comes of Age
Published in Tom Lawry, Hacking Healthcare, 2022
Remote Patient Monitoring: The collection, transmission, evaluation, and communication of individual health data from a patient to their healthcare provider or extended care team from outside a hospital or clinical office (i.e., the patient's home) using personal health technologies including wireless devices, wearable sensors, implanted health monitors, smartphones, and mobile apps. Remote patient monitoring supports ongoing condition monitoring and chronic disease management and can be synchronous or asynchronous, depending upon the patient's needs. The application of emerging technologies, including artificial intelligence (AI) and machine learning, can enable better disease surveillance and early detection, allow for improved diagnoses, and support personalized medicine.
Telemedicine beyond the pandemic: challenges in the pediatric immunology clinic
Published in Expert Review of Clinical Immunology, 2023
Aarti Pandya, Sonya Parashar, Morgan Waller, Jay Portnoy
Telemedicine has come a long way from its early implementations that relied on telephone communication for synchronous encounters. By adding video and the ability to do a physical exam using digital equipment, virtual visits have become a reality. This would not have been practical without the additional availability of EMRs which permit providers to access patient information remotely, thus avoiding unnecessary tests and reducing the risk of prescribing incorrect medications. Once these technologies were combined, their potential beyond simple video visits and proxies for paper charts became apparent. New technologies have made remote patient monitoring and remote therapeutic monitoring possible making it possible to continuously track a patient’s health and to recommend interventions when needed. This, along with computer assisted diagnosis and treatment algorithms incorporated into EMRs are likely to lead to improved care for patients and should go a long way toward meeting the six aims of the IOM report.
Measurement of adherence to inhaled corticosteroids by self-report and electronic medication monitoring
Published in Journal of Asthma, 2023
Ye Sun, Sunit Jariwala, Marina Reznik
EMDs offer unique opportunities for clinicians to remotely monitor medication usage and for patients to utilize this technology for self-management. A growing body of literature on mobile technologies and remote patient monitoring have been proposed as cost-effective ways of improving medication adherence in chronic diseases, especially in children and adolescents (45–47). In this age group, asthma self-management, which includes not only adherence to medications, but also behaviors to monitor and prevent symptoms such as avoiding asthma triggers, is often limited in scope (48). Thus, technology-based interventions offer a potentially viable modality of behavioral change, especially in the management of asthma. Several EMDs that are attachable to inhalers with accompanying mobile applications have been manufactured along with inhalers with built in EMDs (49). However, the cost of these inhalers greatly limits its use and adoptability, especially in lower-income, at risk populations. Additionally, while EMDs are attractive for clinical practice, the integration of this technology into clinical practice as well as with mobile applications has not been extensively studied (49–51). Further studies are needed to assess patient and physician accessibility, integration with electronic health record systems, and cost-effectiveness.
Remote Patient Monitoring: The New Frontier in Telemedicine
Published in Oncology Issues, 2022
Ksenia Gorbenko, Alaina Kessler, Mark Liu, Melanie Besculides, Carol Kisswany, Madhu Mazumdar, Cardinale B. Smith
A particular type of telemedicine, remote patient monitoring, represents the next frontier in technological innovation in virtual longitudinal patient care. Remote patient monitoring involves the transmission of health data, such as vital signs, from patients’ homes to healthcare providers via wearable devices, a mobile app, and/or home hub (where the cancer care team can see inputted patient data and track trends). Studies have shown promising results for remote patient monitoring, with a recent meta-analysis demonstrating a reduction in hospitalizations.18 However, most of these studies neither included patients with cancer nor evaluated the implementation of remote patient monitoring among vulnerable patient populations, and widespread implementation of this technology has been limited. A recent prospective observational study showed the benefits of an interdisciplinary remote patient monitoring program for patients with cancer diagnosed with COVID-19. Remote patient monitoring was associated with a 78 percent relative risk reduction in hospital admissions.19 As such, the expansion of telemedicine utilizing remote patient monitoring is promising for patients with hematological malignancies who are at an increased risk of hospitalization.